1993
7-Benzylidenenaltrexone (BNTX): A selective δ1 opioid receptor antagonist in the mouse spinal cord
Sofuoglu M, Portoghese P, Takemori A. 7-Benzylidenenaltrexone (BNTX): A selective δ1 opioid receptor antagonist in the mouse spinal cord. Life Sciences 1993, 52: 769-775. PMID: 8383271, DOI: 10.1016/0024-3205(93)90240-4.Peer-Reviewed Original ResearchConceptsAntinociceptive ED50 valueDELT IIED50 valuesDelta opioid receptor subtypesOpioid receptor subtypesDelta-opioid receptorsSubtype-selective agonistsAntinociceptive ED50Spinal sitesOpioid receptorsReceptor subtypesSelective agonistBNTXDPDPEMiceAdministrationHand administrationAntinociceptionRecent reportsDAMGONaltribenMorphineAgonistsAntagonistED50
1992
δ-Opioid receptor binding in mouse brain: Evidence for heterogeneous binding sites
Sofuoglu M, Portoghese P, Takemori A. δ-Opioid receptor binding in mouse brain: Evidence for heterogeneous binding sites. European Journal Of Pharmacology 1992, 216: 273-277. PMID: 1327813, DOI: 10.1016/0014-2999(92)90370-j.Peer-Reviewed Original ResearchConceptsMouse brainDelta-opioid receptor agonistDelta opioid receptor subtypesOpioid receptor agonistsBrains of miceOpioid receptor subtypesDelta-opioid receptorsΔ-opioid receptorsDelta opioidOpioid receptorsReceptor agonistReceptor subtypesBrainBinding sitesReceptorsOpioidsNaltribenDPDPEDSLETDADLEAgonistsSubtypesMiceEquipotent
1991
Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes
Sofuoglu M, Portoghese P, Takemori A. Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes. Life Sciences 1991, 49: pl153-pl156. PMID: 1658509, DOI: 10.1016/0024-3205(91)90397-t.Peer-Reviewed Original ResearchConceptsDelta opioid receptor subtypesOpioid receptor subtypesAntinociceptive effectReceptor subtypesAntinociceptive ED50 valueDelta-opioid receptor-selective peptideCross-tolerance studiesReceptor-selective peptideSpinal cordTolerance developmentFurther evidenceDPDPEED50 valuesMiceDADLEDAMGOSignificant increaseDSLETSame pretreatmentSubtypesAdministrationSelective peptidesCordFNA